electroCore to Present at the Canaccord Genuity Growth Conference
ROCKAWAY, NJ, Aug. 02, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will give a corporate presentation and be available for virtual one-on-one meetings at the Canaccord Genuity Growth Conference. The conference is taking place virtually from August 10 - 12, 2021. Details for the presentation are as follows:
Canaccord Genuity Growth Conference:
Date: Thursday, August 12, 2021
Time: 8:30 am EDT
Investors can register for the conference HERE.
Following the conference a webcast replay of the presentation will be available on the Investor section of the company’s website, www.electrocore.com.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
CONTACT: Investors: Rich Cockrell CG Capital 404-736-3838 ecor@cg.capital or Media Contact: Jackie Dorsky electroCore 908-313-6331 Jackie.dorsky@electrocore.com
